We initially explored for inconsistency by a loop-specific approach. Inconsistency was estimated as the difference between direct and indirect estimates (called inconsistency
For acceptability (all-cause discontinuation), there was no evidence of inconsistency (P = 0.9057).
For efficacy, the result of inconsistency test suggested inconsistency existed (P = 0.0230). Therefore, we explored factors that could lead to inconsistency. After excluding three studies with the early treatment, 33 38 42 the result of the inconsistency test was 0.4967, which suggested consistency model was fitted. We conducted a multiple-treatments meta-analysis by inconsistency model before excluding. We also conducted a multiple-treatments meta-analysis by consistency model after excluding.
And then, we compared the results. After excluding the three studies with the early treatment, efficacy and acceptability outcomes did not change substantially, excepting that citalopram and sertraline exchanged the ranking order in SUCRA rank for efficacy, and sertraline and nortriptyline exchanged the ranking order in SUCRA rank for acceptability. The specific data is shown in the S Table- 1 and S Table- 
